help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 8, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1580
A more recent version of this article appeared on February 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/2/555    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Leener, A.
Right arrow Articles by Costagliola, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Leener, A.
Right arrow Articles by Costagliola, S.
Right arrowPubmed/NCBI databases
*OMIM*Protein
*Compound via MeSH
*Substance via MeSH

Submitted on July 15, 2005
Accepted on November 2, 2005

Presence and absence of FSH receptor mutations provide some insights to spontaneous ovarian hyperstimulation syndrome physiopathology

A. De Leener, L. Montanelli, J. Van Durme, H. Chae, G. Smits, G. Vassart, and S. Costagliola*

I.R.I.B.H.M., Faculty of Medicine, Free University of Brussels, 808 Route de Lennik, B-1070, Brussels, Belgium; Department of Obstetrics and Gynaecology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Department of Genetics, Erasme Hospital, Free University of Brussels, 808 Route de Lennik, B-1070, Brussels, Belgium

* To whom correspondence should be addressed. E-mail: scostag{at}ulb.ac.be.

Context: Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of ovarian stimulation treatments. Moreover, four mutations of the FSH receptor (FSHr) were recently described in patients presenting with spontaneous OHSS (sOHSS) of the first trimester of pregnancy with normal levels of hCG.

Objective: To look for novel FSHr mutations in patients with sOHSS associated with different levels of hCG and TSH to:1) find new residues important for FSHr activation and specificity, 2) better delineate the pathophysiology of the different presentations of sOHSS.

Design, intervention, patients: After blood sampling, we sequenced the FSHr from genomic Leukocytes DNA, from eight patients with the sOHSS of the first or second trimester of pregnancy with normal or high hCG levels, or with high TSH levels associated with severe hypothyroidism.

Setting: University laboratory

Main outcome measure: FSHr sequencing and in vitro evaluation of the variation of cAMP production of FSHr mutants.

Results: A new mutation was found in the patient with sOHSS of the first trimester of pregnancy with normal hCG level: I5.54545T, in transmembrane helix V of the FSHr. When tested functionally, this mutant displayed promiscuous activation by both hCG and TSH, together with detectable constitutive activity. In contrast, no mutations were found in the FSHr from the patients with high hCG or TSH levels indicating that, for those seven patients, sOHSS results from the natural promiscuous stimulation of a wild-type FSHr by very high concentrations of hCG or TSH.

Conclusions: sOHSS can at least occur by three different pathophysiological mechanisms.


Key words: FSHr • GPCR • OHSS • hCG




This article has been cited by other articles:


Home page
Journal of Diagnostic Medical SonographyHome page
F. Grochal, C. D. Turner, A. L. Chern, J. Wilters, and P. Jeanty
Sonographic Detection of the Ovarian Hyperreactio Luteinalis in Pregnancy
Journal of Diagnostic Medical Sonography, November 1, 2008; 24(6): 369 - 373.
[Abstract] [PDF]


Home page
EndocrinologyHome page
J. Royer, A. Lefevre-Minisini, G. Caltabiano, T. Lacombe, Y. Malthiery, F. Savagner, L. Pardo, and P. Rodien
The Cloned Equine Thyrotropin Receptor Is Hypersensitive to Human Chorionic Gonadotropin; Identification of Three Residues in the Extracellular Domain Involved in Ligand Specificity
Endocrinology, October 1, 2008; 149(10): 5088 - 5096.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. L. Bogorad, C. Courtillot, C. Mestayer, S. Bernichtein, L. Harutyunyan, J.-B. Jomain, A. Bachelot, F. Kuttenn, P. A. Kelly, V. Goffin, et al.
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors
PNAS, September 23, 2008; 105(38): 14533 - 14538.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Feng, T. Muller, D. Mizrachi, F. Fanelli, and D. L. Segaloff
An Intracellular Loop (IL2) Residue Confers Different Basal Constitutive Activities to the Human Lutropin Receptor and Human Thyrotropin Receptor through Structural Communication between IL2 and Helix 6, via Helix 3
Endocrinology, April 1, 2008; 149(4): 1705 - 1717.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
R. N. Edwards-Silva, C. S. Han, Y. Hoang, and L.-C. Kao
Spontaneous Ovarian Hyperstimulation in a Naturally Conceived Pregnancy With Uncontrolled Hypothyroidism
Obstet. Gynecol., February 1, 2008; 111(2): 498 - 501.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
H. Binder, R. Dittrich, I. Hager, A. Muller, S. Oeser, M. W Beckmann, M. Hamori, P. A Fasching, and R. Strick
Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome
Reproduction, January 1, 2008; 135(1): 107 - 116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhang, Y.-X. Tao, G. L. Ryan, X. Feng, F. Fanelli, and D. L. Segaloff
Intrinsic Differences in the Response of the Human Lutropin Receptor Versus the Human Follitropin Receptor to Activating Mutations
J. Biol. Chem., August 31, 2007; 282(35): 25527 - 25539.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. L. Ryan, X. Feng, C. B. d'Alva, M. Zhang, B. J. Van Voorhis, E. M. Pinto, A. E. F. Kubias, S. R. Antonini, A. C. Latronico, and D. L. Segaloff
Evaluating the Roles of Follicle-Stimulating Hormone Receptor Polymorphisms in Gonadal Hyperstimulation Associated with Severe Juvenile Primary Hypothyroidism
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2312 - 2317.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Bonomi, M. Busnelli, L. Persani, G. Vassart, and S. Costagliola
Structural Differences in the Hinge Region of the Glycoprotein Hormone Receptors: Evidence from the Sulfated Tyrosine Residues
Mol. Endocrinol., December 1, 2006; 20(12): 3351 - 3363.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. M. Allan, A. Garcia, J. Spaliviero, M. Jimenez, and D. J. Handelsman
Maintenance of Spermatogenesis by the Activated Human (Asp567Gly) FSH Receptor During Testicular Regression Due to Hormonal Withdrawal
Biol Reprod, May 1, 2006; 74(5): 938 - 944.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society